MTHFR C677T polymorphism in chronic pancreatitis and pancreatic adenocarcinoma

Cell Biochemistry and Function

Volumn 26, Issue 6, 2008, Pages 659-663

  Nisevic, Ivan ^a   Dinic, Jelena ^a   Nikolic, Aleksandra ^a   Djordjevic, Valentina ^a   Lukic, Snezana ^b   Ugljesic, Milenko ^b   Andjelic Jelic, Marina ^c   Petrovic Stanojevic, Natasa ^c   Radojkovic, Dragica ^a  

^a INSTITUTE OF MOLECULAR GENETICS AND GENETIC ENGINEERING   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c Clinical Centre Zvezdara   (Serbia)

Author keywords

Chronic pancreatitis; Gene polymorphism; MTHFR; Pancreatic adenocarcinoma

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYTOSINE; DNA; THYMINE;

ADULT; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; DNA EXTRACTION; ENVIRONMENTAL FACTOR; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEREDITY; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SERBIA; SMOKING; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; ADULT; AGED; CHRONIC DISEASE; GENE FREQUENCY; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; ODDS RATIO; PANCREATIC NEOPLASMS; PANCREATITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 52649150890     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1487     Document Type: Article

References (23)

1. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120: 682-707.
2. The GLOBOCAN 2002 Database: http://www-dep.iarc.fr/globocan/database.htm [22 May 2007].
3. Ghadirian P, Lynch HT, Krewski D. Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev 2003; 27: 87-93.
4. Duell EJ, Holly EA, Bracci PM, Liu M, Wiencke JK, Kelsey KT. A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J Natl Cancer Inst 2002; 94: 297-306.
5. Fodinger M, Horl WH, Sunder-Plassmann G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol 2000; 13: 20-33.
6. Boldyrev AA. Homocysteinic acid causes oxidative stress in lymphocytes by potentiating toxic effect of NMDA. Bull Exp Biol Med 2005; 140: 33-37.
7. Martin YN, Salavaggione OE, Eckloff BW, Wieben ED, Schaid DJ, Weinshilboum RM. Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics. Pharmacogenet Genomics 2006; 16: 265-277.
8. Schneider JA, Rees DC, Liu YT, Clegg JB. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet 1998; 62: 1258-1260.
9. Djordjevic V, Rakicevic LJ, Mikovic D, et al. Prevalence of factor V leiden, factor V cambridge, factor II G20210A and methylenetetrahydrofolate reductase C677T mutations in healthy and thrombophilic Serbian populations. Acta Haematol 2004; 112: 227-229.
10. Li D, Ahmed M, Li Y, et al. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer, Cancer Epidemiol Bioniarkers Prev 2005; 14: 1470-1476.
11. Kim YI. Folate and methylenetetrahydrofolate reductase polymorphisms: new nutritional and genetic risk factors for pancreatic cancer? Clin Gastroenterol Hepatol 2005; 3: 738-742.
12. Frosst P. Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
13. Radojkovic D, Kusic J. Silver staining of denaturing gradient gel electrophoresis gels. Clin Chem 2000; 46: 883-884.
14. Matsubayashi H, Skinner HG, Iacobuzio-Donahue C, et al. Pancreaticobiliary cancers with deficient methylenetetrahydrofolate reductase genotypes. Clin Gastroenterol Hepatol 2005; 3: 752-760.
15. Wang L, Miao X, Tan W, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer. Clin Gastroenterol Hepatol 2005; 3: 743-751.
16. Friso S, Choi SW, Girelli D, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 2002; 99: 5606-5611.
17. Sato N, Maitra A, Fukushima N, et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 2003; 63: 4158-4166.
18. Ueki T, Toyota M, Sohn T, et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000; 60: 1835-1839.
19. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 2004; 159: 423-443.
20. Pereira TV, Rudnicki M, Pereira AC, Pombo-de-Oliveira MS, Franco RF. 5,10-methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 1956-1963.
21. Talamini G, Bassi C, Falconi M, et al. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci 1999; 44: 1303-1311.
22. Paracchini V, Garte S, Taioli E. MTHFR C677T polymorphism, GSTM1 deletion and male infertility: a possible suggestion of a gene-gene interaction? Biomarkers 2006; 11: 53-60.
23. Lim U, Peng K, Shane B. et al. Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men. J Nutr 2005; 135: 1989-1994.